Injection Peptide Drug Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injection Peptide Drug Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Intravenous Injection
1.2.3 Subcutaneous Injection
1.3 Market by Application
1.3.1 Global Injection Peptide Drug Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Injection Peptide Drug Market Perspective (2017-2028)
2.2 Injection Peptide Drug Growth Trends by Region
2.2.1 Injection Peptide Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Injection Peptide Drug Historic Market Size by Region (2017-2022)
2.2.3 Injection Peptide Drug Forecasted Market Size by Region (2023-2028)
2.3 Injection Peptide Drug Market Dynamics
2.3.1 Injection Peptide Drug Industry Trends
2.3.2 Injection Peptide Drug Market Drivers
2.3.3 Injection Peptide Drug Market Challenges
2.3.4 Injection Peptide Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Injection Peptide Drug Players by Revenue
3.1.1 Global Top Injection Peptide Drug Players by Revenue (2017-2022)
3.1.2 Global Injection Peptide Drug Revenue Market Share by Players (2017-2022)
3.2 Global Injection Peptide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Injection Peptide Drug Revenue
3.4 Global Injection Peptide Drug Market Concentration Ratio
3.4.1 Global Injection Peptide Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injection Peptide Drug Revenue in 2021
3.5 Injection Peptide Drug Key Players Head office and Area Served
3.6 Key Players Injection Peptide Drug Product Solution and Service
3.7 Date of Enter into Injection Peptide Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Injection Peptide Drug Breakdown Data by Type
4.1 Global Injection Peptide Drug Historic Market Size by Type (2017-2022)
4.2 Global Injection Peptide Drug Forecasted Market Size by Type (2023-2028)
5 Injection Peptide Drug Breakdown Data by Application
5.1 Global Injection Peptide Drug Historic Market Size by Application (2017-2022)
5.2 Global Injection Peptide Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Injection Peptide Drug Market Size (2017-2028)
6.2 North America Injection Peptide Drug Market Size by Country (2017-2022)
6.3 North America Injection Peptide Drug Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Injection Peptide Drug Market Size (2017-2028)
7.2 Europe Injection Peptide Drug Market Size by Country (2017-2022)
7.3 Europe Injection Peptide Drug Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Injection Peptide Drug Market Size (2017-2028)
8.2 Asia-Pacific Injection Peptide Drug Market Size by Country (2017-2022)
8.3 Asia-Pacific Injection Peptide Drug Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Injection Peptide Drug Market Size (2017-2028)
9.2 Latin America Injection Peptide Drug Market Size by Country (2017-2022)
9.3 Latin America Injection Peptide Drug Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Injection Peptide Drug Market Size (2017-2028)
10.2 Middle East & Africa Injection Peptide Drug Market Size by Country (2017-2022)
10.3 Middle East & Africa Injection Peptide Drug Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Injection Peptide Drug Introduction
11.1.4 Sanofi Revenue in Injection Peptide Drug Business (2017-2022)
11.1.5 Sanofi Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Injection Peptide Drug Introduction
11.2.4 Teva Revenue in Injection Peptide Drug Business (2017-2022)
11.2.5 Teva Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Detail
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Injection Peptide Drug Introduction
11.3.4 Novo Nordisk Revenue in Injection Peptide Drug Business (2017-2022)
11.3.5 Novo Nordisk Recent Development
11.4 Takeda
11.4.1 Takeda Company Detail
11.4.2 Takeda Business Overview
11.4.3 Takeda Injection Peptide Drug Introduction
11.4.4 Takeda Revenue in Injection Peptide Drug Business (2017-2022)
11.4.5 Takeda Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Detail
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Injection Peptide Drug Introduction
11.5.4 Eli Lilly Revenue in Injection Peptide Drug Business (2017-2022)
11.5.5 Eli Lilly Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Injection Peptide Drug Introduction
11.6.4 AstraZeneca Revenue in Injection Peptide Drug Business (2017-2022)
11.6.5 AstraZeneca Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Injection Peptide Drug Introduction
11.7.4 Novartis Revenue in Injection Peptide Drug Business (2017-2022)
11.7.5 Novartis Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Injection Peptide Drug Introduction
11.8.4 AbbVie Revenue in Injection Peptide Drug Business (2017-2022)
11.8.5 AbbVie Recent Development
11.9 Ipsen
11.9.1 Ipsen Company Detail
11.9.2 Ipsen Business Overview
11.9.3 Ipsen Injection Peptide Drug Introduction
11.9.4 Ipsen Revenue in Injection Peptide Drug Business (2017-2022)
11.9.5 Ipsen Recent Development
11.10 Ferring
11.10.1 Ferring Company Detail
11.10.2 Ferring Business Overview
11.10.3 Ferring Injection Peptide Drug Introduction
11.10.4 Ferring Revenue in Injection Peptide Drug Business (2017-2022)
11.10.5 Ferring Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Injection Peptide Drug Introduction
11.11.4 Merck Revenue in Injection Peptide Drug Business (2017-2022)
11.11.5 Merck Recent Development
11.12 The Medicines
11.12.1 The Medicines Company Detail
11.12.2 The Medicines Business Overview
11.12.3 The Medicines Injection Peptide Drug Introduction
11.12.4 The Medicines Revenue in Injection Peptide Drug Business (2017-2022)
11.12.5 The Medicines Recent Development
11.13 J & J
11.13.1 J & J Company Detail
11.13.2 J & J Business Overview
11.13.3 J & J Injection Peptide Drug Introduction
11.13.4 J & J Revenue in Injection Peptide Drug Business (2017-2022)
11.13.5 J & J Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Injection Peptide Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Intravenous Injection
Table 3. Key Players of Subcutaneous Injection
Table 4. Global Injection Peptide Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Injection Peptide Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Injection Peptide Drug Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Injection Peptide Drug Market Share by Region (2017-2022)
Table 8. Global Injection Peptide Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Injection Peptide Drug Market Share by Region (2023-2028)
Table 10. Injection Peptide Drug Market Trends
Table 11. Injection Peptide Drug Market Drivers
Table 12. Injection Peptide Drug Market Challenges
Table 13. Injection Peptide Drug Market Restraints
Table 14. Global Injection Peptide Drug Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Injection Peptide Drug Market Share by Players (2017-2022)
Table 16. Global Top Injection Peptide Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injection Peptide Drug as of 2021)
Table 17. Ranking of Global Top Injection Peptide Drug Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Injection Peptide Drug Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Injection Peptide Drug Product Solution and Service
Table 21. Date of Enter into Injection Peptide Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Injection Peptide Drug Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Injection Peptide Drug Revenue Market Share by Type (2017-2022)
Table 25. Global Injection Peptide Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Injection Peptide Drug Revenue Market Share by Type (2023-2028)
Table 27. Global Injection Peptide Drug Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Injection Peptide Drug Revenue Market Share by Application (2017-2022)
Table 29. Global Injection Peptide Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Injection Peptide Drug Revenue Market Share by Application (2023-2028)
Table 31. North America Injection Peptide Drug Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Injection Peptide Drug Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Injection Peptide Drug Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Injection Peptide Drug Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Injection Peptide Drug Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Injection Peptide Drug Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Injection Peptide Drug Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Injection Peptide Drug Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Injection Peptide Drug Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Injection Peptide Drug Market Size by Country (2023-2028) & (US$ Million)
Table 41. Sanofi Company Detail
Table 42. Sanofi Business Overview
Table 43. Sanofi Injection Peptide Drug Product
Table 44. Sanofi Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 45. Sanofi Recent Development
Table 46. Teva Company Detail
Table 47. Teva Business Overview
Table 48. Teva Injection Peptide Drug Product
Table 49. Teva Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 50. Teva Recent Development
Table 51. Novo Nordisk Company Detail
Table 52. Novo Nordisk Business Overview
Table 53. Novo Nordisk Injection Peptide Drug Product
Table 54. Novo Nordisk Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 55. Novo Nordisk Recent Development
Table 56. Takeda Company Detail
Table 57. Takeda Business Overview
Table 58. Takeda Injection Peptide Drug Product
Table 59. Takeda Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 60. Takeda Recent Development
Table 61. Eli Lilly Company Detail
Table 62. Eli Lilly Business Overview
Table 63. Eli Lilly Injection Peptide Drug Product
Table 64. Eli Lilly Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 65. Eli Lilly Recent Development
Table 66. AstraZeneca Company Detail
Table 67. AstraZeneca Business Overview
Table 68. AstraZeneca Injection Peptide Drug Product
Table 69. AstraZeneca Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 70. AstraZeneca Recent Development
Table 71. Novartis Company Detail
Table 72. Novartis Business Overview
Table 73. Novartis Injection Peptide Drug Product
Table 74. Novartis Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. AbbVie Company Detail
Table 77. AbbVie Business Overview
Table 78. AbbVie Injection Peptide Drug Product
Table 79. AbbVie Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 80. AbbVie Recent Development
Table 81. Ipsen Company Detail
Table 82. Ipsen Business Overview
Table 83. Ipsen Injection Peptide Drug Product
Table 84. Ipsen Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 85. Ipsen Recent Development
Table 86. Ferring Company Detail
Table 87. Ferring Business Overview
Table 88. Ferring Injection Peptide Drug Product
Table 89. Ferring Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 90. Ferring Recent Development
Table 91. Merck Company Detail
Table 92. Merck Business Overview
Table 93. Merck Injection Peptide DrugProduct
Table 94. Merck Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 95. Merck Recent Development
Table 96. The Medicines Company Detail
Table 97. The Medicines Business Overview
Table 98. The Medicines Injection Peptide DrugProduct
Table 99. The Medicines Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 100. The Medicines Recent Development
Table 101. J & J Company Detail
Table 102. J & J Business Overview
Table 103. J & J Injection Peptide DrugProduct
Table 104. J & J Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 105. J & J Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Injection Peptide Drug Market Share by Type: 2021 VS 2028
Figure 2. Intravenous Injection Features
Figure 3. Subcutaneous Injection Features
Figure 4. Global Injection Peptide Drug Market Share by Application in 2021 & 2028
Figure 5. Cancer Case Studies
Figure 6. Metabolic Disorders Case Studies
Figure 7. Central Nervous System Case Studies
Figure 8. Other Case Studies
Figure 9. Injection Peptide Drug Report Years Considered
Figure 10. Global Injection Peptide Drug Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Injection Peptide Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Injection Peptide Drug Market Share by Region: 2021 VS 2028
Figure 13. Global Injection Peptide Drug Market Share by Players in 2021
Figure 14. Global Top Injection Peptide Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injection Peptide Drug as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Injection Peptide Drug Revenue in 2021
Figure 16. North America Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Injection Peptide Drug Market Share by Country (2017-2028)
Figure 18. United States Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Injection Peptide Drug Market Share by Country (2017-2028)
Figure 22. Germany Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Injection Peptide Drug Market Share by Region (2017-2028)
Figure 30. China Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Injection Peptide Drug Market Share by Country (2017-2028)
Figure 38. Mexico Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Injection Peptide Drug Market Share by Country (2017-2028)
Figure 42. Turkey Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Sanofi Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 45. Teva Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 46. Novo Nordisk Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 47. Takeda Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 48. Eli Lilly Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 49. AstraZeneca Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 50. Novartis Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 51. AbbVie Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 52. Ipsen Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 53. Ferring Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 54. Merck Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 55. The Medicines Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 56. J & J Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Industry Market Size
